Maxim downgraded BioAffinity Technologies (BIAF) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on BIAF: BIAF Upcoming Earnings Report: What to Expect? BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS Disclaimer & DisclosureReport an Issue
